A Phase Ib/II, Multicenter, Open-Label Study to Evaluate Safety, Efficacy, and Pharmacokinetics of YL201 in Combination with Other Anti-Cancer Therapies in Patients with Advanced Solid Tumors

16819YL201-INT-102-02-NCT07407933OpenA Phase Ib/II, Multicenter, Open-Label Study to Evaluate Safety, Efficacy, and Pharmacokinetics of YL201 in Combination with Other Anti-Cancer Therapies in Patients with Advanced Solid TumorsYL201-INT-102-02NCT07407933IndustrialAdultTreatmentI/IILungLiu, StephenGeorgetown University Medical Center : Rossana Zelaya-Ballon; Lombardi Comprehensive Cancer Center : Rossana Zelaya-BallonPhase IOncology GroupLombardi Comprehensive Cancer Center (LCCC)17200Rossana Zelaya-BallonRossana Zelaya-Ballonrjz18@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>